Remus Pharma Live Share Price Today, Share Analysis and Chart

Name: Remus Pharmaceuticals Ltd.: Is Infosys Ltd. worth buying?
Item: Remus Pharmaceuticals Ltd.
Rating: 1.94650
Author: Trendlyne DVM scores

about

Remus Pharmaceuticals Ltd. operates as a pharmaceutical company primarily engaged in the marketing and distribution of finished dosage formulations. The company serves various therapeutic segments, focusing on export markets to enhance its global foo...

703.20 -8.55 (-1.20%)

31.18% Fall from 52W High

1,800

NSE Volume

NSE 05 Jun, 2026 3:31 PM (IST)

Loading... You have run out of DVM views!

Subscribe now to see details

Not Eligible

Expensive Valuation

- / 100

Technically Neutral

50.4 / 100

No estimates available

Remus Pharma Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Remus Pharma Live Share Price Today, Share Analysis and Chart

Remus Pharmaceuticals Ltd. operates as a pharmaceutical company primarily engaged in the marketing and distribution of finished dosage formulations. The company serves various therapeutic segments, focusing on export markets to enhance its global foo...

31.18% Fall from 52W High

SWOT Analysis

Remus Pharma Live Price Chart